← FDA DRUG APPROVALS

FDA ANDA · ANDA205228

TRANEXAMIC ACID

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA205228
TYPE
ANDA
ORIGINAL APPROVAL
2017-07-17
LATEST ACTION
2026-03-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRANEXAMIC ACIDDiscontinued
TRANEXAMIC ACID 100MG/ML · INJECTABLE · INJECTION

Approval history

2026-03-18Labeling · Supplement 5 · standardAP
2022-06-17Labeling · Supplement 3 · standardAP
2018-05-14Labeling · Supplement 1 · standardAP
2017-07-17UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →